FDA Inspection
Par Formulations Private LimitedPar Formulations Private Limited – FDA Inspection, Jun 10, 2026
Record Details
This FDA Inspection record concerns Par Formulations Private Limited, with an inspection on June 10, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · a38f8c1a-1d1c-4370-b5f3-109e9180eab1
Inspection Facts
- Inspection number
- 1321302
- FDA center
- Human Drugs
Other FDA inspections of Par Formulations Private Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 24, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 17, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 17, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Par Formulations Private Limited
- FDA Inspection 1205764 - 2023-03-24
- FDA Inspection 1098295 - 2019-06-21
- FDA Inspection 1000693 - 2016-12-07
- FDA Inspection 927362 - 2015-04-17
- FDA Inspection 855562 - 2013-10-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.